Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy.

Hammer, Christian; Fasching, Peter A; Loehberg, Christian R; Rauh, Claudia; Ekici, Arif B; Jud, Sebastian M; Bani, Mayada R; Beckmann, Matthias W; Strick, Reiner; Niesler, Beate

Hammer, Christian; Fasching, Peter A; Loehberg, Christian R; Rauh, Claudia; Ekici, Arif B; Jud, Sebastian M; Bani, Mayada R; Beckmann, Matthias W; Strick, Reiner; Niesler, Beate.

Affiliation

Hammer C; Institute of Human Genetics, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany.

Pharmacogenomics ; 11(7): 943-50, 2010 Jul.

Article in En | MEDLINE | ID: mdl-20602613

Subject(s)

Anthracyclines/adverse effects; Anthracyclines/therapeutic use; Polymorphism, Single Nucleotide; Receptors, Serotonin, 5-HT3/genetics; Vomiting/chemically induced; Vomiting/genetics; Alleles; Antiemetics/administration & dosage; Antiemetics/therapeutic use; Breast Neoplasms/drug therapy; Breast Neoplasms/genetics; Female; Gene Frequency; Genotype; Humans; Middle Aged; Nausea/chemically induced; Nausea/drug therapy; Serotonin/adverse effects; Serotonin/genetics; Serotonin/therapeutic use; Vomiting/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Anthracyclines / Polymorphism, Single Nucleotide / Receptors, Serotonin, 5-HT3 Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Pharmacogenomics Journal subject: FARMACOLOGIA / GENETICA MEDICA Year: 2010 Document type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google